[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dimerix Ltd (DXB.AX)

Dimerix Ltd (DXB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dimerix Ltd 425 Smith Street Fitzroy VIC 3065 AUS

https://www.dimerix.com P: 130-081-3321 F: +61 893888256

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.

Key Statistics

Overview:

Market Capitalization, $K 129,085
Shares Outstanding, K 600,397
% of Institutional Shareholders 2.45%

Financials:

Annual Sales, $ 5,587 K
Annual Net Income, $ -13,252 K

Growth:

1-Year Return -52.08%
3-Year Return 150.00%
5-Year Return -15.69%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.03
Most Recent Dividend 1.215 on 09/24/99
Next Ex-Dividends Date 09/24/99
Dividend Payable Date 10/29/99
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/23/17

DXB.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -594.54%
Return-on-Assets % -37.73%
Profit Margin % -237.20%
Debt/Equity N/A
Price/Sales 16.91
Price/Book N/A
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.